Invitation to the Extraordinary General Meeting of BB MEDTECH AG
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Invitation to the Extraordinary General Meeting of BB MEDTECH AG, Schaffhausen The shareholders of BB MEDTECH AG are hereby invited to the Extraordinary General Meeting on Wednesday, August 26, 2009, 2:00 p.m.to the SIX Swiss Exchange, ConventionPoint, Selnaustrasse 30, CH-8021 Zurich (doors open at 1.15 p.m.)AGENDAGreeting and statements on the General Meeting.1. Change of corporate purposeThe Board of Directors proposes to the General Meeting ofshareholders that, on condition that the conditions (a), (c) and (e)of the public exchange offer of Vontobel Beteiligungen AG arefulfilled or waived, a new Art. 2 of the Articles of Association beadopted with the following wording:"The purpose of the Company is to hold and manage participations incompanies as well as any kind of financial investments in Switzerlandor abroad. The Company may perform all commercial and financialtransactions that serve its purpose, including the sale of all orsome of its participations and investments. It may purchase equityinterests in other companies, establish branch offices andsubsidiaries and purchase or sell real estate."2. Change of firm nameThe Board of Directors proposes to the General Meeting ofshareholders that, on condition that settlement of the publicexchange offer of Vontobel Beteiligungen AG takes place, the firmname "BB MEDTECH AG" be replaced with the firm name "VT Finance AG".3. Sale of portfolio investments and cashThe Board of Directors proposes to the General Meeting ofshareholders that, on condition that the conditions (a), (c) and (e)of the public exchange offer of Vontobel Beteiligungen AG arefulfilled or waived, the sale of portfolio investments and cash toBellevue Medtech Funds as specified in section 5.4 of the OfferProspectus ("Vereinbarungen der Vontobel mit BB MEDTECH, derenOrganen und Aktionären - Transaktionsvertrag mitBB MEDTECH") be approved.4. Elections to the Board of DirectorsThe Board of Directors proposes to the General Meeting ofshareholders that, on condition that settlement of the publicexchange offer of Vontobel Beteiligungen AG takes place, Messrs. Dr.Martin Sieg Castagnola, Roger Studer and Walter Temperli be electedto the Board of Directors with effect from the settlement date of thepublic exchange offer.5. Discharge of the current members of the Board of DirectorsOn condition that settlement of the public exchange offer of VontobelBeteiligungen AG takes place, the current Board members Heino vonProndzynski, Dr Wolfgang Reim and Laura Rossi will resign with effectfrom the settlement date of the public exchange offer.The Board of Directors proposes to the General Meeting ofshareholders that, on condition that settlement of the publicexchange offer of Vontobel Beteiligungen AG takes place, the currentmembers of the Board of Directors Heino von Prondzynski, Dr. WolfgangReim and Laura Rossi be discharged.6. Election of auditorsThe Board of Directors proposes that, on condition that settlement ofthe public exchange offer of Vontobel Beteiligungen AG takes place,Ernst & Young AG, Bern, be elected as company auditors.GENERALAdmittance cardsShareholders who wish to attend the General Meeting either themselvesor by proxy can obtain their admittance cards and voting records fromBB MEDTECH AG, c/o SIX SAG Aktienregister AG, Postfach, CH-4609Olten, by August 21, 2009, at the latest. The shareholders andbeneficiaries whose names appear in the Share Register on August 21,2009, at 6:00 p.m. shall be entitled to attend and vote at theGeneral Meeting.Granting proxy rightsIf you cannot attend the General Meeting in person, you may choose toauthorize a registered shareholder with voting rights, BB MEDTECH AGor the independent proxy holder as contemplated by Art. 689c of theSwiss Law of Obligations, Dr. Mark A. Reutter, attorney-at-law,Walder Wyss & Partner, Seefeldstrasse 123, CH-8034 Zurich. If theindependent proxy holder receives no voting instructions in writingfor all or individual items on the agenda, he will exercise hisvoting rights in support of the motions proposed by the Board ofDirectors. He only exercises his voting rights and cannot representany other proposals, election nominations and the like. If you granta proxy to BB MEDTECH AG, your voting rights will always be exercisedin support of the motions proposed by the Board of Directors.Signed but blank proxy forms shall be treated as a mandate of BBMEDTECH AG to endorse the motions proposed by the Board of Directors.Proxies to BB MEDTECH AG with instructions explicitly different willbe handed over to the independent proxy holder.Depository account representativesDepositary account representatives as contemplated by Art. 689d ofthe Swiss Law of Obligations are requested to notify BB MEDTECH AG ofthe number of shares they will be representing as soon as possible,no later thanAugust 26, 2009, at the access check at the General Meeting.http://hugin.info/130286/R/1332122/315429.pdf --- End of Message ---BB MEDTECH AGVordergasse 3 Schaffhausen SwitzerlandWKN: AONFN4; ISIN: CH0038390016; Index: IGSP;Listed: Investment Companies in SIX Swiss Exchange;
Datum: 03.08.2009 - 07:30 Uhr
Sprache: Deutsch
News-ID 4237
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 407 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Invitation to the Extraordinary General Meeting of BB MEDTECH AG"
steht unter der journalistisch-redaktionellen Verantwortung von
BB MEDTECH AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
